Singular Genomics Systems, Inc. NASDAQ:OMIC

Founder-led company

Singular Genomics Systems stock price today

$19.988
+0.38
+1.98%
Financial Health
0
1
2
3
4
5
6
7
8
9

Singular Genomics Systems stock price monthly change

+124.26%
month

Singular Genomics Systems stock price quarterly change

+124.26%
quarter

Singular Genomics Systems stock price yearly change

+4294.62%
year

Singular Genomics Systems key metrics

Market Cap
48.35M
Enterprise value
63.32M
P/E
-0.81
EV/Sales
82.77
EV/EBITDA
-0.75
Price/Sales
102.93
Price/Book
0.30
PEG ratio
-0.02
EPS
-1.31
Revenue
2.49M
EBITDA
-90.06M
Income
-96.21M
Revenue Q/Q
-48.78%
Revenue Y/Y
52.94%
Profit margin
-11879.61%
Oper. margin
-12220.52%
Gross margin
-3.14%
EBIT margin
-12220.52%
EBITDA margin
-3617.07%
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Singular Genomics Systems stock price history

Singular Genomics Systems stock forecast

Singular Genomics Systems financial statements

Singular Genomics Systems, Inc. (NASDAQ:OMIC): Profit margin
Jun 2023 505K -25.57M -5064.95%
Sep 2023 462K -22.36M -4839.83%
Dec 2023 1.08M -23.24M -2150.69%
Mar 2024 442K -25.02M -5661.54%
Singular Genomics Systems, Inc. (NASDAQ:OMIC): Analyst Estimates
Sep 2025 7.81M -21.70M -277.7%
Oct 2025 7.81M -654.53M -8373.47%
Dec 2025 9.69M -658.32M -6792.64%
Mar 2026 12.89M -15.73M -122%
  • Analysts Price target

  • Financials & Ratios estimates

Singular Genomics Systems, Inc. (NASDAQ:OMIC): Earnings per share (EPS)
2024-03-18 -0.34 -0.32
2024-05-14 -0.35 -10.21
Singular Genomics Systems, Inc. (NASDAQ:OMIC): Debt to assets
Jun 2023 283978000 65.59M 23.1%
Sep 2023 284518000 85.49M 30.05%
Dec 2023 265467000 86.46M 32.57%
Mar 2024 239101000 82.40M 34.46%
Singular Genomics Systems, Inc. (NASDAQ:OMIC): Cash Flow
Jun 2023 -19.99M -35.08M 618K
Sep 2023 -16.81M -24.70M 0
Dec 2023 -18.90M 651K 72K
Mar 2024 -23.70M 31.57M 0

Singular Genomics Systems alternative data

Singular Genomics Systems, Inc. (NASDAQ:OMIC): Employee count
Aug 2023 276
Sep 2023 269
Oct 2023 269
Nov 2023 269
Dec 2023 284
Jan 2024 284
Feb 2024 284
Apr 2024 255
May 2024 255
Jun 2024 255
Jul 2024 255

Singular Genomics Systems other data

21.21% -31.00%
of OMIC is owned by hedge funds
15.09M -22.08M
shares is hold by hedge funds

Singular Genomics Systems, Inc. (NASDAQ:OMIC): Insider trades (number of shares)
Period Buy Sel
Sep 2024 122416 175
Nov 2024 0 695
Dec 2024 0 180
Transaction Date Insider Security Shares Price per share Total value Source
Sale
SPAVENTA ANDREW director, officer: Chief Execut..
Common Stock 180 $20.16 $3,629
Option
SPAVENTA ANDREW director, officer: Chief Execut..
Restricted Stock Units 486 N/A N/A
Option
SPAVENTA ANDREW director, officer: Chief Execut..
Common Stock 486 N/A N/A
Option
MEETER DALEN officer: Chief Financial Officer
Common Stock 209 N/A N/A
Option
MEETER DALEN officer: Chief Financial Officer
Restricted Stock Units 209 N/A N/A
Option
GLEZER ELI N. officer: Chief Scientific Officer
Common Stock 250 N/A N/A
Option
GLEZER ELI N. officer: Chief Scientific Officer
Restricted Stock Units 250 N/A N/A
Option
SPAVENTA ANDREW director, officer: Chief Execut..
Restricted Stock Units 1,907 N/A N/A
Option
SPAVENTA ANDREW director, officer: Chief Execut..
Common Stock 1,907 N/A N/A
Sale
SPAVENTA ANDREW director, officer: Chief Execut..
Common Stock 695 $22.55 $15,669
Insider Compensation
Mr. Andrew Spaventa (1985) Founder, Chief Executive Officer & Chairperson of the Board
$474,560
Dr. Eli N. Glezer Ph.D. (1969) Founder & Chief Scientific Officer
$380,620
Mr. Dalen Meeter (1978) Senior Vice President of Fin.
$315,070
Monday, 23 December 2024
businesswire.com
businesswire.com
globenewswire.com
Thursday, 19 September 2024
globenewswire.com
benzinga.com
Thursday, 12 September 2024
globenewswire.com
Tuesday, 13 August 2024
seekingalpha.com
Tuesday, 30 July 2024
globenewswire.com
Monday, 15 July 2024
globenewswire.com
Monday, 24 June 2024
benzinga.com
Friday, 21 June 2024
globenewswire.com
Wednesday, 29 May 2024
globenewswire.com
Thursday, 23 May 2024
seekingalpha.com
Tuesday, 14 May 2024
Seeking Alpha
Monday, 4 March 2024
GlobeNewsWire
Tuesday, 14 November 2023
Seeking Alpha
Tuesday, 24 October 2023
GlobeNewsWire
Wednesday, 20 September 2023
InvestorPlace
Friday, 8 September 2023
GlobeNewsWire
Wednesday, 9 August 2023
Seeking Alpha
Wednesday, 26 July 2023
GlobeNewsWire
Thursday, 1 June 2023
GlobeNewsWire
Saturday, 13 May 2023
Seeking Alpha
Tuesday, 9 May 2023
Zacks Investment Research
Tuesday, 25 April 2023
GlobeNewsWire
Thursday, 2 March 2023
Seeking Alpha
Zacks Investment Research
Thursday, 16 February 2023
GlobeNewsWire
Wednesday, 15 February 2023
Seeking Alpha
Wednesday, 21 December 2022
GlobeNewsWire
  • What's the price of Singular Genomics Systems stock today?

    One share of Singular Genomics Systems stock can currently be purchased for approximately $19.99.

  • When is Singular Genomics Systems's next earnings date?

    Unfortunately, Singular Genomics Systems's (OMIC) next earnings date is currently unknown.

  • Does Singular Genomics Systems pay dividends?

    No, Singular Genomics Systems does not pay dividends.

  • How much money does Singular Genomics Systems make?

    Singular Genomics Systems has a market capitalization of 48.35M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 280.52% to 2.91M US dollars. Singular Genomics Systems made a loss 94.82M US dollars in net income (profit) last year or -$10.21 on an earnings per share basis.

  • What is Singular Genomics Systems's stock symbol?

    Singular Genomics Systems, Inc. is traded on the NASDAQ under the ticker symbol "OMIC".

  • What is Singular Genomics Systems's primary industry?

    Company operates in the Healthcare sector and Medical - Instruments & Supplies industry.

  • How do i buy shares of Singular Genomics Systems?

    Shares of Singular Genomics Systems can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are Singular Genomics Systems's key executives?

    Singular Genomics Systems's management team includes the following people:

    • Mr. Andrew Spaventa Founder, Chief Executive Officer & Chairperson of the Board(age: 40, pay: $474,560)
    • Dr. Eli N. Glezer Ph.D. Founder & Chief Scientific Officer(age: 56, pay: $380,620)
    • Mr. Dalen Meeter Senior Vice President of Fin.(age: 47, pay: $315,070)
  • Is Singular Genomics Systems founder-led company?

    Yes, Singular Genomics Systems is a company led by its founders Mr. Andrew Spaventa and Dr. Eli N. Glezer Ph.D..

  • How many employees does Singular Genomics Systems have?

    As Jul 2024, Singular Genomics Systems employs 255 workers.

  • When Singular Genomics Systems went public?

    Singular Genomics Systems, Inc. is publicly traded company for more then 4 years since IPO on 27 May 2021.

  • What is Singular Genomics Systems's official website?

    The official website for Singular Genomics Systems is singulargenomics.com.

  • Where are Singular Genomics Systems's headquarters?

    Singular Genomics Systems is headquartered at 10931 North Torrey Pines Road, La Jolla, CA.

  • How can i contact Singular Genomics Systems?

    Singular Genomics Systems's mailing address is 10931 North Torrey Pines Road, La Jolla, CA and company can be reached via phone at 858 333 7830.

Singular Genomics Systems company profile:

Singular Genomics Systems, Inc.

singulargenomics.com
Exchange:

NASDAQ

Full time employees:

255

Industry:

Medical - Instruments & Supplies

Sector:

Healthcare

Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology to build products for researchers and clinicians to advance science and medicine. The company manufactures G4 Instrument, a benchtop next generation sequencer to produce genetic sequencing results, as well as associated menu of consumable kits. It also offers PX Integrated Solution that combines single cell analysis, spatial analysis, genomics, and proteomics in one integrated instrument providing a versatile multiomics solution. The company has partnerships with Agilent Technologies, Dovetail Genomics, Lexogen, New England Biolab, QIAGEN, Roche, Twist Bioscience, and Watchmaker Genomics to validate their library preparation kits on the G4, as well as the Broad Institute of MIT and Harvard to connect the G4 to Terra platform, a data platform. Singular Genomics Systems, Inc. was incorporated in 2016 and is headquartered in La Jolla, California.

10931 North Torrey Pines Road
La Jolla, CA 92037

CIK: 0001850906
ISIN: US82933R1005
CUSIP: 82933R100